Pipeline · Bill → Law
Step 1
Introduced
Feb 17, 2023
Step 2
Referred
Feb 24, 2023
Financial Services · E&C · Judiciary +1
Step 3
Committee
Feb 28, 2023
Reported out
Step 4
House floor
Step 5
Senate
Jul 23, 2024
Passed Senate
Step 6
Resolve Changes
Step 7
Signed
Sep 13, 2024
SummaryCRS Summary
This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
Similar Bills · 1 matches
| Bill | Text overlap | Status |
|---|---|---|
| S. 2227— Preventing the Financing of Illegal Synthetic Drugs Act | 87% | INCORPORATED |
Roll Call Votes · 1
Timeline · 25 actions
Sep 13, 2024
Signed by President.
Sep 13, 2024
Became Public Law No: 118-79.
Sep 11, 2024
Presented to President.
Jul 24, 2024
Message on Senate action sent to the House.
Jul 23, 2024
Senate Committee on Banking, Housing, and Urban Affairs discharged by Unanimous Consent.
Jul 23, 2024
Passed Senate without amendment by Unanimous Consent.
May 30, 2023
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
May 22, 2023
Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
May 22, 2023
Committee on the Judiciary discharged.
May 22, 2023
Committee on Energy and Commerce discharged.
May 22, 2023
Placed on the Union Calendar, Calendar No. 55.
May 22, 2023
Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
May 22, 2023
Considered under suspension of the rules.
May 22, 2023
DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
May 22, 2023
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
May 22, 2023
Considered as unfinished business.
May 22, 2023
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228).ROLL CALLpass
May 22, 2023
Motion to reconsider laid on the table Agreed to without objection.
Feb 28, 2023
Committee Consideration and Mark-up Session Held.
Feb 28, 2023
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
Feb 24, 2023
Referred to the Subcommittee on Health.
Feb 17, 2023
Introduced in House
Feb 17, 2023
Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 17, 2023
Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 17, 2023
Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.